Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by vicarioon Nov 20, 2016 12:41am
149 Views
Post# 25485985

RE:RE:RE:In good hands

RE:RE:RE:In good handsI was merely noting the coincidence that the stock has setlled ~$0.02 away from the warrant exercise price.  I'm sure it means nothing... just an observation.

I think it fell hard from $2 down to $1.30 because those who had PP shares and free trading shares sold their free trading shares because they knew they couldn't sell their PP shares and weren't comfortable with the exposure.  I also think buyers ran away because it was well understood the market could potentially be flooded with PP holders dumping their shares.  

Having said this the volume has been somewhat light in consideration of the PP shares now being free trading and the price has firmed up; we haven't seen a flood of selling yet; I suspect everyone is looking towards the next quarterly report before acting.  If I had to guess, we will revisit the recent lows of ~$1.30 if there's a hiccup with earnings or we will rip higher towards $2 if the results and guidance are excellent.

Good luck to us.


Bullboard Posts